Cell therapies, including chimeric antigen receptor (CAR) T-cell therapy, are emerging as promising treatments, especially for hematological malignancies. However, many challenges remain in the development of this emerging class of therapeutics, from deepening responses in blood-based tumors to expanding efficacy in solid tumors. Download this resource and explore how single cell solutions can help uncover molecular insights into cell therapeutic efficacy and toxicity, transforming the way we approach immune cell therapies for cancer.